These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8195605)

  • 1. A primate model for chancroid.
    Totten PA; Morton WR; Knitter GH; Clark AM; Kiviat NB; Stamm WE
    J Infect Dis; 1994 Jun; 169(6):1284-90. PubMed ID: 8195605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A humoral immune response confers protection against Haemophilus ducreyi infection.
    Cole LE; Toffer KL; Fulcher RA; San Mateo LR; Orndorff PE; Kawula TH
    Infect Immun; 2003 Dec; 71(12):6971-7. PubMed ID: 14638786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.
    Fulcher RA; Cole LE; Janowicz DM; Toffer KL; Fortney KR; Katz BP; Orndorff PE; Spinola SM; Kawula TH
    Infect Immun; 2006 May; 74(5):2651-8. PubMed ID: 16622201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
    Lagergård T
    Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swine model of Haemophilus ducreyi infection.
    Hobbs MM; San Mateo LR; Orndorff PE; Almond G; Kawula TH
    Infect Immun; 1995 Aug; 63(8):3094-100. PubMed ID: 7622236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.
    Purcell BK; Richardson JA; Radolf JD; Hansen EJ
    J Infect Dis; 1991 Aug; 164(2):359-67. PubMed ID: 1856485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron and virulence of Haemophilus ducreyi in a primate model.
    Sturm AW
    Sex Transm Dis; 1997 Feb; 24(2):64-8. PubMed ID: 9111750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental human infection with Haemophilus ducreyi.
    Spinola SM; Wild LM; Apicella MA; Gaspari AA; Campagnari AA
    J Infect Dis; 1994 May; 169(5):1146-50. PubMed ID: 8169411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.
    Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C
    Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.
    Wood GE; Dutro SM; Totten PA
    Infect Immun; 2001 Aug; 69(8):4726-33. PubMed ID: 11447144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects.
    Al-Tawfiq JA; Thornton AC; Katz BP; Fortney KR; Todd KD; Hood AF; Spinola SM
    J Infect Dis; 1998 Dec; 178(6):1684-7. PubMed ID: 9815220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid.
    Wising C; Mölne L; Jonsson IM; Ahlman K; Lagergård T
    Microbes Infect; 2005 May; 7(5-6):867-74. PubMed ID: 15876546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid.
    Desjardins M; Filion LG; Robertson S; Kobylinski L; Cameron DW
    Infect Immun; 1996 May; 64(5):1778-88. PubMed ID: 8613391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilus ducreyi: clinical disease and pathogenesis.
    Al-Tawfiq JA; Spinola SM
    Curr Opin Infect Dis; 2002 Feb; 15(1):43-7. PubMed ID: 11964905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid.
    Leduc I; Fusco WG; Choudhary N; Routh PA; Cholon DM; Hobbs MM; Almond GW; Orndorff PE; Elkins C
    Infect Immun; 2011 Aug; 79(8):3168-77. PubMed ID: 21646451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutropenia restores virulence to an attenuated Cu,Zn superoxide dismutase-deficient Haemophilus ducreyi strain in the swine model of chancroid.
    San Mateo LR; Toffer KL; Orndorff PE; Kawula TH
    Infect Immun; 1999 Oct; 67(10):5345-51. PubMed ID: 10496915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilus ducreyi requires an intact flp gene cluster for virulence in humans.
    Spinola SM; Fortney KR; Katz BP; Latimer JL; Mock JR; Vakevainen M; Hansen EJ
    Infect Immun; 2003 Dec; 71(12):7178-82. PubMed ID: 14638812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cumulative experience with Haemophilus ducreyi 35000 in the human model of experimental infection.
    Al-Tawfiq JA; Harezlak J; Katz BP; Spinola SM
    Sex Transm Dis; 2000 Feb; 27(2):111-4. PubMed ID: 10676978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid.
    Hansen EJ; Lumbley SR; Richardson JA; Purcell BK; Stevens MK; Cope LD; Datte J; Radolf JD
    J Immunol; 1994 Jan; 152(1):184-92. PubMed ID: 8254191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus ducreyi: pathogenesis and protective immunity.
    Lagergård T
    Trends Microbiol; 1995 Mar; 3(3):87-92. PubMed ID: 7773593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.